Q10 and Gingivitis - a phase IV clinical study of FDA data

Summary:

Gingivitis is reported as a side effect among people who take Q10 (coenzyme q - 10), especially for people who are female, 60+ old, also take Zometa, and have Pain.

The phase IV clinical study analyzes which people have Gingivitis when taking Q10. It is created by eHealthMe based on reports of 32,909 people who have side effects when taking Q10 from the FDA, and is updated regularly.

What is Q10?

Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,259 Q10 users. Check the latest studies of Q10.

What is Gingivitis?

Gingivitis (inflammation of gums) is found to be associated with 886 drugs and 803 conditions by eHealthMe. Check the latest studies of Gingivitis.

On Jul, 14, 2026

32,909 people reported to have side effects when taking Q10.
Among them, 28 people (0.09%) have Gingivitis.

Among these 28 people:

What is the gender of people who have Gingivitis when taking Q10? *

female: 82.14 %
male: 17.86 %

What is the age of people who have Gingivitis when taking Q10? *

What are other drugs people take besides Q10? *

What are other side effects people have besides Gingivitis? *

Loose Tooth: 13 people, 46.43%
Stress And Anxiety: 12 people, 42.86%
Injury: 11 people, 39.29%
Pain: 11 people, 39.29%
Hypophagia (reduced food intake): 11 people, 39.29%
Emotional Distress: 11 people, 39.29%
Discomfort: 11 people, 39.29%
Dizziness: 11 people, 39.29%
Breast Cancer Metastatic: 10 people, 35.71%
Taste - Impaired: 10 people, 35.71%

What are the existing conditions these people have? *

Pain: 13 people, 46.43%
Stress And Anxiety: 11 people, 39.29%
Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 10 people, 35.71%
Breast Cancer: 10 people, 35.71%
Multiple Myeloma (cancer of the plasma cells): 4 people, 14.29%
High Blood Pressure: 3 people, 10.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 10.71%
Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 2 people, 7.14%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 2 people, 7.14%
Immunodeficiency Common Variable: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Q10 and have Gingivitis?

- Check whether Gingivitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Q10:

Q10 (34,259 reports)

Gingivitis treatments and more:

Gingivitis (9,610 reports)

Browse all side effects of Q10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gingivitis:

Gingivitis (886 drugs)

Browse all the conditions that are associated with Gingivitis:

Gingivitis (803 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 (the active ingredients of Q10) and Q10 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.